Recent Headlines
Luke Roush Named Vice President of Global Marketing at TransEnterix
Roush is responsible for setting and executing TransEnterix’s worldwide marketing and commercialization strategy, which includes communicating the benefits of the company’s SPIDER® Surgical System to hospitals, surgeons and patients. - May 14, 2010 - TransEnterix
AnaSpec Introduces ClearPoint™ β-Amyloid Custom Peptides
AnaSpec, the world’s largest provider of β-amyloid peptide and Alzheimer’s research reagents , has introduced its ClearPoint™ β-Amyloid custom peptide synthesis service. ClearPoint™ peptides are AnaSpec’s trademark collection of heavy or stable isotope... - May 12, 2010 - AnaSpec, EGT Group
Wockhardt Foundation and Sattad Welfare Association Join Hands for a Noble Cause
A mega medical camp was organized by Wockhardt Foundation in collaboration with Sattad Welfare organization at Badarbaug, Masjid Bunder on 2nd May 2010. A dedicated team which included Dr. Shailesh Nangare along with Dr. Sumit Patwari did a thorough medical examination of the poor, weak and needy... - May 09, 2010 - Wockhardt Foundation
RayBiotech Announces Biomarker Grant Awardees
RayBiotech, Inc., the Protein Array Pioneer Company, has announced the winners of its Biomarker Discovery Pilot Grant program. In total, 18 award recipients were chosen for grants of up to $20,000 each, redeemable for RayBiotech products and services. "By offering these grants," states Dr. - May 06, 2010 - RayBiotech, Inc
AnaSpec Introduces Novel Solid Support AMC Resin
AnaSpec has announced the development of a novel solid support AMC resin for facile solid-phase synthesis of peptide-AMCs. - May 06, 2010 - AnaSpec, EGT Group
Former Ms. India Universe Gul Panag Joins the Advisory Board of the Prestigious Wockhardt Foundation
Gul Panag who has set a perfect example for beauty with a purpose, has joined as a member of the advisory board of the Wockhardt Foundation. - May 05, 2010 - Wockhardt Foundation
New SensoLyte® SIRT1 Assay Kit Offers Industry’s Longest Wavelength
AnaSpec has introduced SIRT1 assay kits in the green range (Ex/Em=490/520 nm). - May 02, 2010 - AnaSpec, EGT Group
Mass Deworming & Eye Screening Camp Held for Children: a Wockhardt Foundation Initiative
A medical camp was conducted by the Mobile Medical Unit of Wockhardt Foundation in Pratiksha Nagar BMC School at Jogeshwari on Thursday 29th April 2010. - May 02, 2010 - Wockhardt Foundation
Huzaifa Khorakiwala Launches the Youth Social Responsibility Movement in Mumbai
Zealous Launch of Youth Social Responsibility Movement at D. Y. Patil College in Mumbai creating Social Awakening among the youth of today. - May 01, 2010 - Wockhardt Foundation
National Brain Tumor Society’s 16th Annual Bay Area Brain Tumor Walk Raising Essential Funds for Brain Tumor Research
National Brain Tumor Society will host a fundraising walk and community day in San Francisco on Saturday, May 1, 2010. Over 2,500 will gather for a 5K walk through scenic Golden Gate Park to raise awareness and essential funds. - April 30, 2010 - National Brain Tumor Society
AnaSpec Introduces New MMP Recombinant Proteins
AnaSpec has announced the release of three new MMP recombinant proteins, MMP-1, MMP-9 and MMP-12. These proteins, derived from the catalytic domain of the proteins, are supplied as activated proteins (activation by APMA is not necessary). They can be used as positive controls for the SensoLyte®... - April 25, 2010 - AnaSpec, EGT Group
Health Decisions CEO to Explore the Role of Operations in Adaptive Research at Adaptive Designs for Clinical Drug Development, April 29
Michael Rosenberg, founder of adaptive-focused CRO, will discuss how flexible clinical operations support the new FDA Draft Guidance on adaptive design - April 25, 2010 - Health Decisions
Bio-Med QC, LLC Announces New Test Procedure to Yield Improved USP Results
Bio-Med QC, LLC announced a new test procedure at the Indian Pharmacists Alliance & Community Pharmacies of Indiana Joint Annual Convention in Indianapolis to improve proficiency test results by an additional 5% when conducting quality system tests of personal aseptic technique. USP Chapter... - April 22, 2010 - Bio-Med QC
Mega Health Camps in Mumbai & Baroda: A Wockhardt Foundation Initiative
On 18th April 2010 a Mega Diabetes Camp was held by Wockhardt Foundation in Baroda, Gujarat & simultaneously another medical camp was held at Worli, Mumbai on the same day. - April 22, 2010 - Wockhardt Foundation
1 Lakh Patients in First 100 days: A Breakthrough by Wockhardt Foundation
After successfully examining 100,000 patients by the first quarter of 2010, which was the total of last year’s achievement. Wockhardt Foundation is fully geared up for more, and this indeed is a remarkable achievement, by the Mobile Medical Unit. - April 21, 2010 - Wockhardt Foundation
Health Decisions Expands the Agile Clinical Network with the Addition of African CRO ClinResearch
International research network’s continued growth strengthens its aim to raise standards of efficiency and quality for global clinical trials. - April 15, 2010 - Health Decisions
Wockhardt Foundation Collaborates with AmeriCares India for a Noble Cause on World Health Day
A mega health check up camp was conducted by Wockhardt Foundation and AmeriCares India on 7th April 2010, ‘World Health Day’, in remote interiors of Kalyan, as an initiative by the leading healthcare NGOs to make cities healthier. The camp kick started at 8.30 am, wherein a thorough... - April 10, 2010 - Wockhardt Foundation
TransEnterix SPIDER® Surgical System Now in Use at Hospitals Across the U.S.
Platform creates new class of minimally invasive surgery called 'Flexible Laparoscopy' - April 07, 2010 - TransEnterix
Wockhardt Foundation's Mobile Medical Unit Achieves 50,000 Free Consultations, Screenings, and Treatment of Poor Patients in the First 3 Months of 2010
Wockhardt Foundation a secular not – for – profit organization completed 50,000 medical check ups along with the distribution of free medicines through its 2 Mobile Medical Unit programmes in the first 3 months of 2010. Wockhardt Foundation has already achieved half of last year’s achievement. - March 27, 2010 - Wockhardt Foundation
AnaSpec Introduces New Selection of RGD GO™ Peptides
As part of its GO™ Peptides collection, AnaSpec has introduced a selection of cyclic and non-cyclic RGD peptides. - March 05, 2010 - AnaSpec, EGT Group
AnaSpec Introduces New SensoLyte® 520 Total GSH Quantitation Assay
After the successful launch of its SensoLyte® 520 Thiol Quantitation Assay Kit (patent pending), AnaSpec has released the SensoLyte® 520 Total GSH Assay Kit (patent pending). - March 04, 2010 - AnaSpec, EGT Group
Congenix Adds Russian Presence to Health Decisions’ Agile Clinical Network
CRO based in Moscow joins Health Decisions’ worldwide network of research organizations dedicated to maximizing the efficiency of global trials - March 04, 2010 - Health Decisions
AnaSpec Introduces New MESA qPCR Mastermixes
AnaSpec is pleased to announce the availability of new MESA FAST and BLUE qPCR Mastermixes as part of its growing product catalog. - February 28, 2010 - AnaSpec, EGT Group
AnaSpec Collects Food for Alameda County Community Food Bank
AnaSpec is pleased to announce that AnaSpec employees collected ninety pounds of food. - February 26, 2010 - AnaSpec, EGT Group
New White Paper Reports the Five Essentials for Minimizing Clinical Development Risk
CRO Health Decisions explains how a systematic risk mitigation system can prevent undue FDA rejection - February 20, 2010 - Health Decisions
Botanical Wisdom Releases: Rapid Cell Infusion
Botanical Wisdom releases their line of Rapid Cell Infusion which contains 25 new products. These 25 new products promote a healthier lifestyle and are all made with their faster acting Bio-Enhanced Extraction Process. - February 19, 2010 - Botanical Wisdom
Institute for Integrated Healthcare Appointed as Pharmacy Advisor to MidAtlantic Business Group on Health
Pharmaceuticals-Related Benefits Consultancy Will Maximize Pharmaceutical Value for Business Coalition Members - February 17, 2010 - Institute for Integrated Healthcare
AnaSpec’s Published References Pass 900
As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 900. Products cited include AnaSpec’s custom and catalog peptides, antibodies, assay kits, dyes, standard amino acids, unusual amino acids and synthesis... - February 12, 2010 - AnaSpec, EGT Group
AnaSpec Introduces New SensoLyte® Anti-PLP Assay Kits
AnaSpec, has announced the release of two new multiple sclerosis (MS)/experimental autoimmune encephalomyelitis (EAE) related ELISA assays kits, the SensoLyte® Anti-PLP(139-151) Assay Kit and the SensoLyte® Anti-PLP(178-191) Assay Kit. - February 11, 2010 - AnaSpec, EGT Group
Health Decisions Exceeds Goals for Universal Flu Vaccine Study
CRO completed startup and enrollment of Phase II study in less than three months. - February 05, 2010 - Health Decisions
Biomarker Discovery Grant Deadline Extended
RayBiotech, Inc., today announced that they are extending the deadline for submitting applications for its Biomarker Discovery Pilot Grant program. RayBiotech will now accept applications for the pilot grants through February 22nd, 2010. “The last-minute surge in interest in the grant program has been overwhelming,” said Brett Burkholder, Director of Marketing & Business Development for RayBiotech, Inc. - February 02, 2010 - RayBiotech, Inc
Role of YAP in Cancer Revealed Using EGFR Phosphorylation Array
A study, published in the December 2009 issue of Nature Cell Biology, identified amphiregulin (AREG) as the key effector molecule in YAP-mediated proliferation of breast epithelial cells. Since AREG is a a diffusible, secreted factor, it represents a new potential drug target for cancer. Two antibody arrays from RayBiotech were instrumental in this discovery; one is a unique array detecting phosphorylation of EGFR family receptors at multiple sites. - January 29, 2010 - RayBiotech, Inc
Selexis, GE Healthcare/Wave, Charles River, and Irvine Scientific Offering Complementary Technical Seminar
Half day seminar highlighting technological advances and approaches to accelerating your clinical development of biologics. - January 27, 2010 - Selexis SA
Selexis to Develop Antibody Cell Line for Neogenix
Selexis and Neogenix Oncology enter into research services agreement Geneva, Switzerland, and Great Neck, New York Selexis SA ("Selexis") and Neogenix Oncology, Inc. (“Neogenix”) today jointly announced a Research Services Agreement for the rapid development of a... - January 26, 2010 - Selexis SA
Health Decisions CEO Authors First Complete Guide to Adaptive Clinical Research
Wiley Publishers Releases “The Agile Approach to Adaptive Research: Optimizing Efficiency in Clinical Development,” by Michael Rosenberg, MD, MPH. - January 25, 2010 - Health Decisions
AnaSpec Products Used in Over 400 Patents
The number of patents (both filed and awarded) that cite AnaSpec’s products has passed 400. - January 24, 2010 - AnaSpec, EGT Group
Blue Sky Biotech and Protein Attachment Technologies Announce Global Exclusive Licensing Agreement
Blue Sky Biotech, Inc. (Blue Sky) and Protein Attachment Technologies, LLC (PA Tech) announced today that they have entered into a global, exclusive license agreement covering PA Tech’s proprietary Template Directed Assembly (TDA™) technology for use in High-Throughput Screening [HTS] of drug candidates against membrane-associated protein targets. - January 24, 2010 - Blue Sky Biotech
AnaSpec to Host Bone Marrow Donor Drive
AnaSpec, Inc. has partnered with AADP to host a bone marrow donor drive on the AnaSpec campus on February 1, 2010. The goal of the event is to raise awareness around bone marrow donations and add new donors to the bone marrow donor registry. The event will take place in AnaSpec’s cafeteria... - January 20, 2010 - AnaSpec, EGT Group
Adaptive Clinical Research is Expanding Opportunities in Personalized Medicine: CED Invites Health Decisions to Discuss
Health Decisions CEO Dr. Michael Rosenberg will forecast the future of molecular testing at the CED 2010 Biotech Conference - January 09, 2010 - Health Decisions
Two Long-Established Independent IRBs Discussing Merger
Two Independent Review Boards, responsible for the review of human subject research are discussing a merger to utilize their combined 46 years of experience to create a new Limited Liability Corporation. - January 07, 2010 - Ethical and Independent Review Services
AnaSpec Introduces Its Longest-Wavelength Dye, HiLyte Fluor™ 750
Highlighting its collection of high performance HiLyte Fluor™ dyes, AnaSpec has introduced HiLyte Fluor™ 750. Spectrally similar to Cy7™ dye, HiLyte Fluor™ 750 dye is the longest-wavelength HiLyte Fluor™ dye currently available. Its fluorescence emission maximum at... - January 02, 2010 - AnaSpec, EGT Group
AnaSpec Adds Z-Fish™ MMP Antibodies to MMP Research Portfolio
AnaSpec has introduced the industry’s most comprehensive collection of anti-MMP zebrafish (Z-Fish™) specific antibodies. - December 23, 2009 - AnaSpec, EGT Group
Wiley Press to Release 'The Agile Approach to Adaptive Research: Optimizing Efficiency in Clinical Development'
Michael Rosenberg, MD, MPH, provides a comprehensive guide to the adaptive methods that are shaping the future of clinical trials - December 19, 2009 - Health Decisions
Genescient Receives Additional Angel Funding
Genescient Corporation receives an additional $500,000 in angel funding. - December 17, 2009 - Genescient Corporation
NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont®
The National Eye Institute (NEI) awarded a $2.18 million grant to Aciont Inc. to help fund its development of a non-invasive, passive diffusion-based treatment for severe, non-infectious uveitis. - December 12, 2009 - Aciont Inc.
RayBiotech Introduces Multiplex ELISA Detecting 200 Human Proteins
RayBiotech, the Protein Array Pioneer Company, has just introduced the Quantibody® Human Cytokine Array 4000 (or Human Q4000, catalog number QAH-CAA-4000), which can quantitatively detect expression of 200 different proteins in a single experiment. The kit consists of 5 different quantitative... - December 12, 2009 - RayBiotech, Inc
AnaSpec Introduces α & β -Synuclein Recombinant Proteins
AnaSpec has announced the release of two new recombinant proteins, a-synuclein (SNCA) and b-Synuclein (SNCB). These proteins, along with g-synuclein (SNCG), are members of the synuclein family of small proteins expressed primarily in neural tissue and in some tumors.1 Synuclein proteins, found only... - November 26, 2009 - AnaSpec, EGT Group
Gates Foundation Funds Functional Genetics, Inc. to Study TSG101 Antibody Targeting of HIV-Infected Cells
Functional Genetics, Inc. today announced a grant from the Bill & Melinda Gates Foundation to pursue an innovative approach for antibody-based targeting of HIV/AIDS. Under the terms of the agreement, Functional Genetics will investigate the use of TSG101 antibody targeting of HIV-infected cells... - November 23, 2009 - Functional Genetics, Inc.
KLIXAR Joins Health Decisions’ Global Network of CROs Advocating Higher Efficiency Standards
Latin American CRO is now a certified partner in Health Decisions’ Agile Clinical Network, dedicated to improving processes and systems across global trials - November 20, 2009 - Health Decisions
AnaSpec Introduces SensoLyte 520 Calpain Kit
AnaSpec has announced the release of the SensoLyte 520 Calpain Activity Assay Kit, the industry’s first longest wavelength FRET based calpain assay. Optimized for detecting calpain activity, this kit contains a novel internally quenched 5-FAM/QXLTM 520 FRET substrate. Cleavage of this FRET... - November 20, 2009 - AnaSpec, EGT Group